Loading…
Loading…
The Gabelli Healthcare and Wellness Trust (NYSE: GRX - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 5,720 shares of The Gabelli Healthcare and Wellness Trust stock in a transaction that occurred on Thursday, October 1st. The stock was purchased at an average price of $9.41 per share, with a total value of $53,825.20.
The Gabelli Healthcare and Wellness Trust (NYSE: GRX - Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 6,216 shares, a growth of 48.3% from the August 31st total of 4,191 shares. Based on an average daily trading
The Gabelli Healthcare & Wellness Trust is a diversified, closed-end management investment company whose investment objective is long-term growth of capital. Healthcare underperformed the broader market in April and May before rebounding sharply in June, helped by a sell-off in technology and AI stocks. Managed care was the quarter's most consistent outperformer.
RYE, N.Y., Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable September 23, 2026 to common shareholders of record on September 16, 2026.
RYE, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable on June 23, 2026 to common shareholders of record on June 15, 2026.
The Gabelli Healthcare & WellnessRx Trust offers defensive exposure amid 2026's tech-driven market euphoria, with the healthcare sector's resilience highlighted. GRX trades at a compelling -10% discount to NAV and features attractive valuation metrics: 15x P/E, 2.5x P/B, and 0.95x P/S. The fund's diversified portfolio spans healthcare equipment, providers, pharma, and consumer staples, with a value mid-cap tilt per Morningstar.
Gabelli Equity Trust (NYSE:GAB) has quietly become one of the most beloved income vehicles among retail investors, and the math behind that loyalty is straightforward: a 9.5% annualized yield paid quarterly, a founder who keeps buying shares with his own money, and a recent rights offering oversubscribed by more than $117 million.
Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by Gabelli Funds that has quietly paid quarterly distributions for more than 14 consecutive years.